Funded Startups in Languedoc-Roussillon
Among the 32 most recent disclosed rounds in Languedoc-Roussillon, the largest disclosed amount is $83M (Qair, Energy, round date 2023-08-07).
Among the 32 most recent disclosed rounds in Languedoc-Roussillon, the largest disclosed amount is $83M (Qair, Energy, round date 2023-08-07). That figure stands out against the rest of the table’s disclosed highs (e.g., $75M for Plug In Digital on 2021-11-24 and $73M for Sweep on 2022-04-04), while many other rounds cluster in the $2M–$23M range. The data also shows an “AI + health/biotech” adjacency: four entries are explicitly in Biotechnology (SeqOne Genomics 2025-05-22 $23M; Sensorion 2024-02-09 $54M; Kinvent 2024-01-18 $17M; Advicenne 2022-12-05 $5M) and four are explicitly in Health Care (CILcare 2024-12-04 $22M; Biodol Therapeutics 2024-05-21 $8M; MedinCell 2022-09-05 $20M; Quantum Surgical 2021-10-19 $47M). Temporal concentration is visible as well: multiple rounds land in mid-2024 (e.g., Deepbloo 2024-06-18 $540K; Biodol Therapeutics 2024-05-21 $8M; SCOP3 2024-05-16 $6M), with the most recent round dated 2025-07-13 (Justclip, Energy, $2M) and the oldest shown dated 2021-02-18 (AcuSurgical, Health Care, $7M).
Most recent rounds
32 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Languedoc-Roussillon list, and is it a true outlier versus the next-largest disclosed amounts?
The largest disclosed round is $83M for Qair (Energy) on 2023-08-07. The next-largest disclosed amounts in the table are close by at $75M (Plug In Digital, 2021-11-24) and $73M (Sweep, 2022-04-04), so Qair is the top end, but not the only “very large” round.
Do health/biotech-oriented categories cluster, or is the mix evenly distributed across sectors?
Biotechnology appears 4 times (SeqOne Genomics $23M on 2025-05-22; Sensorion $54M on 2024-02-09; Kinvent $17M on 2024-01-18; Advicenne $5M on 2022-12-05). Health Care also appears 4 times (CILcare $22M on 2024-12-04; Biodol Therapeutics $8M on 2024-05-21; MedinCell $20M on 2022-09-05; Quantum Surgical $47M on 2021-10-19), indicating a repeated life-sciences concentration rather than a uniform sector spread.
Which stage labels are most common, and how often does the table avoid giving a clear disclosed stage?
“Series Unknown” is the most frequent disclosed label, appearing in multiple rows such as SeqOne Genomics (2025-05-22, $23M), Sensorion (2024-02-09, $54M), and Elements (2023-12-07, $54M). There is also one explicitly “undisclosed” amount (So-Tec on 2024-05-16), and one “undisclosed” appears as the amount for PannTheraPi (2023-06-23).
Are there tight time windows where several rounds are concentrated, especially around mid-2024?
Yes. In May–June 2024, several rounds cluster: SCOP3 closed 2024-05-16 for $6M, Biodol Therapeutics closed 2024-05-21 for $8M, and Deepbloo closed 2024-06-18 for $540K. Separately, mid-2025 is also active: Justclip (2025-07-13, $2M) and Eco-Tech Ceram (2025-06-02, $18M) bookend the top of the table.
Which entries look like low-end outliers in disclosed amounts compared to the smallest disclosed rounds?
The smallest disclosed amount in the table is $50K (Hughy, Internet Services, 2023-10-15). That low-end point contrasts with many other smaller disclosed rounds around $540K (Deepbloo 2024-06-18; PeopleSpheres 2023-09-06), and with the broader $2M–$23M band seen across multiple entries (e.g., Justclip $2M on 2025-07-13 and Celest Science $2M on 2025-04-22).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.